Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CERS

Cerus Corp

Dec 12 • 04:00PM ET

1.78

Dollar change -0.03
Percentage change -1.66	%

Healthcare • Medical Devices • USA • NASD

Peers: QDEL BIO HCSG AEMD ARWR AXDX MMSI FATE INSP XERS

| Held by: ARKK ARKG IWM VTI VXF IWO SCHA VTWO VHT IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.11	Insider Own	5.04%	Shs Outstand	185.63M	Perf Week	2.30%
Market Cap	330.57M	Forward P/E	-	EPS next Y	-0.08	Insider Trans	-1.28%	Shs Float	176.36M	Perf Month	-5.82%
Income	-19.73M	PEG	-	EPS next Q	-0.01	Inst Own	79.28%	Short Float	3.76%	Perf Quarter	-14.01%
Sales	176.23M	P/S	1.88	EPS this Y	45.71%	Inst Trans	12.29%	Short Ratio	4.38	Perf Half Y	-1.11%
Book/sh	0.29	P/B	6.18	EPS next Y	33.33%	ROA	-9.98%	Short Interest	6.62M	Perf Year	7.23%
Cash/sh	0.41	P/C	4.37	EPS next 5Y	-	ROE	-38.81%	52W Range	1.38 - 2.59	Perf YTD	-17.59%
Dividend Est.	-	P/FCF	-	EPS past 5Y	13.81%	ROI	-15.10%	52W High	-31.14%	Beta	1.24
Dividend TTM	-	Quick Ratio	1.92	Sales past 5Y	16.80%	Gross Margin	55.30%	52W Low	29.45%	ATR (14)	0.11
Dividend Ex-Date	-	Current Ratio	2.59	EPS Y/Y TTM	61.30%	Oper. Margin	-19.00%	RSI (14)	50.15	Volatility	4.70% 5.61%
Employees	288	Debt/Eq	1.83	Sales Y/Y TTM	14.71%	Profit Margin	-11.19%	Recom	1.67	Target Price	3.90
Option/Short	Yes / Yes	LT Debt/Eq	1.44	EPS Q/Q	60.70%	Payout	-	Rel Volume	0.59	Prev Close	1.81
Sales Surprise	-0.32%	EPS Surprise	37.50%	Sales Q/Q	15.70%	Earnings	Oct 30 AMC	Avg Volume	1.51M	Price	1.78
SMA20	0.51%	SMA50	1.97%	SMA200	-6.39%	Trades		Volume	890,569	Change	-1.66%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-12-24	Initiated	Craig Hallum	Buy	$5
Jan-20-23	Downgrade	BTIG Research	Buy → Neutral
Jan-17-23	Downgrade	Stephens	Overweight → Equal-Weight	$3.75
Oct-08-20	Resumed	BTIG Research	Buy	$9
Jun-16-20	Resumed	Cantor Fitzgerald	Overweight	$9
Feb-26-20	Initiated	BTIG Research	Buy	$7
Nov-13-19	Upgrade	BTIG Research	Neutral → Buy	$7
Aug-28-19	Initiated	Stifel	Buy
Aug-23-19	Resumed	Stephens	Overweight
Jan-05-18	Resumed	Cantor Fitzgerald	Overweight
Dec-08-17	Resumed	BTIG Research	Neutral
Jul-07-16	Resumed	Cantor Fitzgerald	Buy	$9
Dec-17-15	Downgrade	Wedbush	Outperform → Neutral
May-02-14	Reiterated	MLV & Co	Buy	$8.50 → $6
Apr-24-13	Reiterated	Cantor Fitzgerald	Buy	$5.50 → $6
Mar-15-13	Reiterated	MLV & Co	Buy	$7.50 → $8.50
Apr-17-12	Initiated	Cantor Fitzgerald	Buy	$5.50
Feb-29-12	Upgrade	Robert W. Baird	Neutral → Outperform	$3 → $6
Nov-10-11	Reiterated	MLV & Co	Buy	$4 → $5
Jun-03-11	Initiated	Wedbush	Outperform	$4

Show Previous Ratings

Nov-13-24 08:30AM	Cerus Corporation to Participate in Upcoming Investor Conferences (Business Wire)
Oct-31-24 02:11PM	Q3 2024 Cerus Corp Earnings Call (Thomson Reuters StreetEvents) -8.72%
05:01AM	Cerus Corp (CERS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Oct-30-24 05:10PM	Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:06PM	Cerus: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Loading…
04:00PM	Cerus Corporation Announces Third Quarter 2024 Financial Results (Business Wire)
Oct-29-24 09:16AM	Cerus Corp (CERS) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-18-24 08:30AM	Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024 (Business Wire)
08:30AM	Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting (Business Wire)
08:25AM	Cerus price target lowered to $3 from $6 at Stifel (TipRanks)
Oct-16-24 04:00PM	Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe (Business Wire) -9.44%
Oct-09-24 03:49PM	Cerus Corp (CERS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Positive EBITDA (GuruFocus.com) +8.72%
Sep-06-24 01:47AM	Insider Selling: CFO Kevin Green Sells 82,657 Shares of Cerus Corp (CERS) (GuruFocus.com)
Aug-01-24 05:10PM	Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -9.73% +14.95%
04:07PM	Cerus: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Loading…
04:00PM	Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range (Business Wire)
Jul-18-24 08:30AM	Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024 (Business Wire) -6.36%
Jul-02-24 04:00PM	Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors (Business Wire)
Jun-21-24 08:30AM	Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion (Business Wire)
Jun-14-24 08:30AM	Cerus Corporation Celebrates World Blood Donor Day 2024 (Business Wire)
May-22-24 08:30AM	Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference (Business Wire)
May-03-24 10:40AM	Cerus Corporation (NASDAQ:CERS) Q1 2024 Earnings Call Transcript (Insider Monkey) -7.95%
06:48AM	Q1 2024 Cerus Corp Earnings Call (Thomson Reuters StreetEvents)
03:58AM	Cerus Corp (CERS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-02-24 08:59PM	CERS Stock Earnings: Cerus Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:04PM	Cerus Corp (CERS) Q1 2024 Earnings: Revenue Surpasses Estimates, Net Loss Narrows (GuruFocus.com)
04:04PM	Cerus: Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces First Quarter 2024 Financial Results (Business Wire)
Apr-18-24 08:30AM	Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024 (Business Wire)
Mar-26-24 08:30AM	Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets Doubling Previous Shelf Life (Business Wire)
08:00AM	Loading…
Mar-19-24 08:00AM	Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients (Business Wire) +9.68%
Mar-15-24 01:49AM	Insider Sell: President and CEO William Greenman Sells 125,926 Shares of Cerus Corp (CERS) (GuruFocus.com)
01:48AM	Insider Sell: COO Vivek Jayaraman Sells 53,041 Shares of Cerus Corp (CERS) (GuruFocus.com)
Mar-07-24 01:40PM	Cerus Corp (CERS) Posts Narrowed Q4 Net Loss and Achieves Adjusted EBITDA Breakeven (GuruFocus.com)
11:46AM	Cerus Corporation (NASDAQ:CERS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-06-24 06:23AM	Q4 2023 Cerus Corp Earnings Call (Thomson Reuters StreetEvents) +21.61%
Mar-05-24 09:53PM	CERS Stock Earnings: Cerus Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -6.13%
04:26PM	Cerus: Q4 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results (Business Wire)
Feb-23-24 11:56AM	12 Best Rising Penny Stocks To Buy (Insider Monkey)
Feb-20-24 08:30AM	Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024 (Business Wire)
Feb-01-24 08:30AM	Cerus Corporation to Participate in Upcoming Investor Conferences (Business Wire) +8.84%
Jan-15-24 09:30AM	3 Growth Stocks That Could Go Parabolic in 2024 (Motley Fool)
Jan-08-24 08:30AM	Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update (Business Wire) +5.61%
Nov-03-23 09:19AM	Cerus Corporation (NASDAQ:CERS) Q3 2023 Earnings Call Transcript (Insider Monkey) +8.81%
08:30AM	Cerus Corporation to Participate in Upcoming Investor Conferences (Business Wire)
Nov-02-23 06:43PM	Cerus Corp (CERS) Q3 2023 Earnings: Product Revenue Stable, Operating Expenses Decrease by 4% (GuruFocus.com) +15.22%
05:25PM	Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:20PM	Cerus: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Third Quarter 2023 Financial Results (Business Wire)
Oct-19-23 08:30AM	Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023 (Business Wire)
Oct-10-23 08:30AM	Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting (Business Wire) +8.02%
Sep-27-23 08:30AM	Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer (Business Wire)
Sep-12-23 08:30AM	Cerus Corporation to Participate in the 2023 Cantor Global Healthcare Conference (Business Wire)
Aug-02-23 05:15PM	Cerus (CERS) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -17.98%
04:11PM	Cerus: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Second Quarter 2023 Financial Results (Business Wire)
Jul-31-23 12:36PM	Cerus (NASDAQ:CERS) investors are sitting on a loss of 60% if they invested three years ago (Simply Wall St.)
Jul-19-23 08:30AM	Cerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023 (Business Wire) +5.42%
Jul-03-23 05:13PM	12 Best NASDAQ Penny Stocks to Buy (Insider Monkey) -7.76%
Jun-15-23 08:30AM	Cerus Corporation Announces Symposium and Abstracts at the 33rd Regional ISBT Congress (Business Wire)
Jun-14-23 08:30AM	Cerus Corporation Celebrates World Blood Donor Day 2023 (Business Wire)
Jun-07-23 10:30AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jun-05-23 08:30AM	Cerus Corporation Announces Follow-on Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate (Business Wire)
May-30-23 07:16AM	With 72% institutional ownership, Cerus Corporation (NASDAQ:CERS) is a favorite amongst the big guns (Simply Wall St.) +5.70%
May-04-23 05:15PM	Cerus (CERS) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:10PM	Cerus: Q1 Earnings Snapshot (AP Finance)
04:00PM	Cerus Corporation Announces First Quarter 2023 Financial Results (Business Wire)
May-02-23 12:25PM	7 Best Cathie Wood Stocks for Your May 2023 Buy List (InvestorPlace) -8.09%
Apr-20-23 08:30AM	Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023 (Business Wire) -5.84%
Apr-18-23 10:54AM	Cerus Corporation (NASDAQ:CERS) Might Not Be As Mispriced As It Looks (Simply Wall St.)
Mar-10-23 09:24AM	Too Cheap to Ignore: Cathie Wood Snaps Up These 2 Stocks Under $10 (TipRanks)
Mar-09-23 11:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Feb-28-23 04:00PM	Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results (Business Wire) -7.34%
Feb-21-23 11:00AM	Cerus (NASDAQ:CERS) shareholders have endured a 43% loss from investing in the stock a year ago (Simply Wall St.) -8.00%
Feb-15-23 08:30AM	Cerus Corporation to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 (Business Wire)
Feb-10-23 08:30AM	Cerus Corporation to Participate in Upcoming Investor Conferences (Business Wire)
Jan-19-23 11:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jan-09-23 08:30AM	Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update (Business Wire) -28.04%
Dec-21-22 05:50AM	Cerus Corporation's (NASDAQ:CERS) recent 9.2% pullback adds to one-year year losses, institutional owners may take drastic measures (Simply Wall St.) +7.83%
Nov-09-22 05:58AM	Cerus Third Quarter 2022 Earnings: US$0.048 loss per share (vs US$0.072 loss in 3Q 2021) (Simply Wall St.)
Nov-04-22 08:00AM	Cerus Corporation to Participate in Upcoming Investor Conferences (Business Wire) +11.24%
Nov-03-22 05:55PM	Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Cerus Corporation Announces Third Quarter Financial Results (Business Wire)
Nov-02-22 01:52PM	Cerus Corporation Announces Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate (Business Wire) -5.42%
Nov-01-22 08:00AM	Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage (Business Wire)
Oct-20-22 08:30AM	Cerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022 (Business Wire)
Sep-26-22 08:00AM	Cerus Corporation Announces Workshop and Abstracts at the 2022 AABB Annual Meeting (Business Wire)
Sep-21-22 09:35AM	After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for Cerus (CERS) (Zacks)
Sep-14-22 11:55AM	Investors in Cerus (NASDAQ:CERS) have made a decent return of 59% over the past five years (Simply Wall St.)
Sep-13-22 11:17AM	Zimmer (ZBH) Surges 4.2%: Is This an Indication of Further Gains? (Zacks) -7.49%
Aug-29-22 09:35AM	Down 20.4% in 4 Weeks, Here's Why Cerus (CERS) Looks Ripe for a Turnaround (Zacks)
Aug-24-22 07:58AM	Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks (Motley Fool)
Aug-12-22 08:00AM	Cerus Corporation Acknowledges Growing Monkeypox Outbreak and Public Health Emergency (Business Wire)
Aug-05-22 01:00PM	Cerus (CERS) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-04-22 05:25PM	Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Cerus Corporation Announces Another Record Quarter and Reiterates Full Year 2022 Product Revenue Guidance Range (Business Wire)
Jul-28-22 09:48AM	Cathie Woods Top 15 Small-Cap Stock Picks (Insider Monkey)
Jul-21-22 08:00AM	Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022 (Business Wire)
Jul-14-22 12:00PM	Cerus (CERS) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BJERKHOLT ERIC	Director	Dec 12 '24	Proposed Sale	1.78	20,000	35,700		Dec 12 04:41 PM
Green Kevin Dennis	Chief Financial Officer	Sep 04 '24	Sale	2.15	54,272	116,826	536,093	Sep 05 05:05 PM
Green Kevin Dennis	Chief Financial Officer	Sep 03 '24	Sale	2.18	28,385	61,919	590,365	Sep 05 05:05 PM
KEVIN D GREEN	Officer	Sep 04 '24	Proposed Sale	2.15	54,272	116,826		Sep 04 04:14 PM
KEVIN D GREEN	Officer	Sep 03 '24	Proposed Sale	2.18	28,385	61,919		Sep 03 04:28 PM
Jensen Chrystal	Chief Legal Officer	Aug 15 '24	Sale	2.06	16,667	34,417	474,245	Aug 19 04:35 PM
CHRYSTAL NIKOLE JENSEN	Officer	Aug 15 '24	Proposed Sale	2.07	16,667	34,427		Aug 15 04:41 PM
Benjamin Richard J	Chief Medical Officer	Aug 02 '24	Sale	2.50	21,605	54,012	438,007	Aug 07 04:07 PM
RICHARD J BENJAMIN	Officer	Aug 02 '24	Proposed Sale	2.50	21,605	54,012		Aug 02 04:09 PM
Shan Hua	Director	May 13 '24	Buy	1.99	2,500	4,975	32,386	May 14 06:30 PM
NACHTSHEIM JAMI K	Director	May 10 '24	Buy	1.79	2,000	3,578	108,362	May 13 05:09 PM
Witney Frank	Director	May 09 '24	Buy	1.89	20,000	37,800	180,059	May 10 08:17 PM
Swisher Daniel N JR	Director	May 09 '24	Buy	1.88	2,500	4,689	107,045	May 09 05:15 PM
Green Kevin Dennis	Chief Financial Officer	Mar 14 '24	Sale	1.97	21,497	42,444	618,750	Mar 14 09:53 PM
Green Kevin Dennis	Chief Financial Officer	Mar 13 '24	Sale	2.02	21,058	42,438	640,247	Mar 14 09:53 PM
Moore Carol	SVP Reg. & Quality	Mar 13 '24	Sale	2.02	20,619	41,553	490,623	Mar 14 09:49 PM
Jensen Chrystal	Chief Legal Officer	Mar 13 '24	Sale	2.06	17,460	35,915	508,736	Mar 14 09:47 PM
Jensen Chrystal	Chief Legal Officer	Mar 14 '24	Sale	1.97	17,824	35,192	490,912	Mar 14 09:47 PM
Jayaraman Vivek K	Chief Operating Officer	Mar 13 '24	Sale	2.06	26,247	53,990	905,447	Mar 14 09:33 PM
Jayaraman Vivek K	Chief Operating Officer	Mar 14 '24	Sale	1.97	26,794	52,902	878,653	Mar 14 09:33 PM
Greenman William Mariner	President and CEO	Mar 14 '24	Sale	2.02	63,611	128,195	3,181,281	Mar 14 09:30 PM
Greenman William Mariner	President and CEO	Mar 13 '24	Sale	2.06	62,315	128,182	3,244,892	Mar 14 09:30 PM
CORASH LAURENCE M	Chief Scientific Officer	Mar 13 '24	Sale	2.06	14,067	28,936	2,354,100	Mar 14 09:22 PM
CORASH LAURENCE M	Chief Scientific Officer	Mar 14 '24	Sale	1.97	14,360	28,352	2,339,740	Mar 14 09:22 PM
Benjamin Richard J	Chief Medical Officer	Mar 13 '24	Sale	2.06	17,377	35,744	477,350	Mar 14 09:15 PM
Benjamin Richard J	Chief Medical Officer	Mar 14 '24	Sale	1.97	17,738	35,022	459,612	Mar 14 09:15 PM
Benjamin Richard J	Chief Medical Officer	Mar 08 '24	Sale	2.40	29,378	70,457	478,061	Mar 12 06:10 PM
BJERKHOLT ERIC	Director	Dec 13 '23	Buy	1.62	10,000	16,200	142,133	Dec 13 05:55 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CERS

Cerus Corp

Upgrade your FINVIZ experience